Skip to content

Science Not yet confirmed elsewhere1 publisher 2 min read Published

Three bisphenols mixed at low doses disrupted human breast organoids from most donors

Tufts and Boston University researchers report that low-dose BPA, BPS and BPF together disrupted human breast organoids, while each alone changed little. It is preclinical work, and persistence and any link to disease remain untested.

The Scientist · Science desk

Send a correction

What happened

  • The organoids were grown from breast tissue donated by 13 healthy young women and contain several types of breast cells.
  • Over about three weeks of development they were exposed to individual chemicals and mixtures, including hormone disruptors, metabolism-affecting chemicals and known or suspected carcinogens.
  • Different chemicals affected tissue development in different ways, and the three common bisphenols BPA, BPS and BPF gave the most striking result.
  • The bisphenol concentrations were very low, comparable to levels detected in human blood and urine.
  • In the mixture-exposed organoids, gene programs for extracellular matrix remodeling and epithelial plasticity switched on, alongside widespread DNA methylation remodeling.

Why it matters

  • What it limits constraint Testing each bisphenol alone, the usual unit, would have registered relatively few changes in this model, so it can understate what the same chemicals do together.
  • What's now possible capability Human organoids let researchers test breast tissue development directly, where much prior knowledge rests on animal models and lab-grown cells that cannot fully reproduce human tissue.
  • Who has to decide decision Whether mixture testing becomes a standard depends on follow-up the authors name: whether the changes persist, contribute to later disease and yield risk biomarkers.

Kuperwasser, the senior corresponding author, explained the dose choice in terms of real exposure. "We intentionally used concentrations of chemicals that were relevant to real-world exposure rather than the very high doses sometimes used in toxicology studies. We also tested a mixture of these because people are typically exposed to multiple chemicals at the same time," she said [10].

The readout was built for the job. The authors wrote that they developed an AI-assisted screening platform "capable of quantitatively measuring developmental disruption and morphogenetic alterations across organoids exposed to chemicals" [11]. They then analyzed changes in gene activity and DNA modifications [14].

The paper's title is "Environmental chemical mixtures reprogram mammary epithelial development to epigenetic states associated with breast cancer" [5]. The tissue came from healthy women, and GEN's report frames the outcome as changes that could influence susceptibility to breast disease later in life [4].

We think this supports adding mixture arms to organoid screens. It does not yet support new exposure limits, because that step needs data a dish cannot give. Kuperwasser put a condition on her own conclusion. "If these results are validated by additional studies, they could change how we think about cancer prevention," she said [1].

The thing this doesn't tell you is how many of the 13 donors responded. The report says only that the mixture disrupted organoids from most of them [6][8].

What to watch

  • Follow-up studies testing whether the organoid changes persist in human tissues or contribute to later disease, as the authors propose.
  • Independent validation of the result, the condition Kuperwasser attached to any change in how cancer prevention is approached.
  • Work testing whether the molecular changes yield biomarkers that help assess breast cancer risk.

Clarity's read

What the record supports and how the coverage leans. The claims behind it follow.

Reality

Evidence50
Adoption
Not scored
Hype gap+10
Incentives
Not scored
Confidence45
Why these scores

Claim ledger

Ranked by verification strength, evidence, and original report placement.

  1. [1]

    Kuperwasser said: 'If these results are validated by additional studies, they could change how we think about cancer prevention.'

    Reported Supported Source: Charlotte Kuperwasser, Tufts University School of Medicine2 sources— create a free account to open themView cited source
  2. [2]

    Much of what scientists know about how chemicals affect breast tissue comes from animal models or laboratory-grown cells that cannot fully reproduce the complexity of human tissue.

  3. [3]

    The results lay the groundwork for investigating whether these molecular changes persist in human tissues, contribute to disease later in life, and could yield biomarkers to help assess breast cancer risk.

Get this ledger inside ChatGPT. Ask about any of our stories and the answer brings its figure, each claim’s verdict and the sources. Free, no account.

Add to ChatGPTAdd to Claude

Sources

1 independent publisher whose own reporting we read for this story.

  1. genengnews.com

    1 article · October 16, 2026

    Exposure to Common Endocrine-Disrupting Chemicals May Alter Normal Breast Development

Share your take

Let Clarity write the post for you.

Signed-in readers get a short post drafted on this story in the register they choose — narrative, analytical, or a direct position — editable to the last word before it goes anywhere. The share buttons at the top of this story work without an account.

Topics and entities

Follow any of these and your For You feed starts watching them — no settings page required.

Topics

Loading related stories